8-K - 8-K - Aligos Therapeutics, Inc. (0001799448) () - 8.01 / 9.01

Form 8-K - Current report: SEC Accession No. 0001193125-26-154927

Filing Date: 2026-04-14

Accepted: 2026-04-14 16:17:32

Documents: 12

Period of Report: 2026-04-14

Items: Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits

Aligos Therapeutics, Inc. (Filer) CIK : 0001799448 (see all company filings) EIN. : 000000000 | State of Incorp.: DE | Fiscal Year End: 1231 Type: 8-K | Act: 34 | File No.: 001-39617 | Film No.: 26861021 SIC : 2836 Biological Products, (No Diagnostic Substances) (CF Office: 03 Life Sciences)

1 | 8-K | d107028d8k.htm iXBRL | 8-K

2 | EX-99.1 | d107028dex991.htm | EX-99.1

3 | XBRL TAXONOMY EXTENSION SCHEMA | algs-20260414.xsd | EX-101.SCH

4 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | algs-20260414_lab.xml | EX-101.LAB